UCSD Technology Licensed by Urigen Pharmaceuticals
|
 |
By Bob Nidever in NEWS_Licensing Published: Saturday, 13 September 08 - 06:13 PM (GMT -08:00) Last Updated: Saturday, 13 September 08 - 10:40 PM (GMT -08:00) |
| ||
"For the millions of sufferers of a bladder condition called painful bladder syndrome/interstitial cystitis, hope is on the way, developed by urologic surgeon and researcher Lowell Parsons, M.D. of the University of California, San Diego Medical Center.
"What our team has identified is an experimental drug therapy that can provide pain relief to patients within 20 minutes," said Parsons, professor of surgery at UC San Diego School of Medicine. "Depending on the individual, in my experience, one dose can last from 6 to 40 hours. The ability of the therapy to provide immediate relief is something entirely new for sufferers of interstitial cystitis."
"The new drug therapy combination has been licensed by UC San Diego Technology Transfer & Intellectual Property Services to Urigen Pharmaceuticals, Inc. for further clinical development and commercialization. [MedicalNewsToday] MORE
<-- Back
